WCA-814 | CAS#2951858-45-8 | Androgen Receptor Antagonist | Hsp90

MedKoo Cat#: 123037 | Name: WCA-814

Description:

WARNING: This product is for research use only, not for human or veterinary use.

WCA-814 is an Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugate for Targeted Therapy of Castration-Resistant Prostate Cancer.

Chemical Structure

WCA-814

CAS#2951858-45-8

Theoretical Analysis

MedKoo Cat#: 123037

Name: WCA-814

CAS#: 2951858-45-8

Chemical Formula: C46H53ClN10O5

Exact Mass: 860.3900

Molecular Weight: 861.45

Elemental Analysis: C, 64.14; H, 6.20; Cl, 4.12; N, 16.26; O, 9.29

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

WCA-814; WCA814; WCA 814

IUPAC/Chemical Name

N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(4-(3-(2,4-dihydroxy-5-isopropylphenyl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)benzyl)piperazin-1-yl)methyl)piperidin-1-yl)pyridazine-3-carboxamide

InChi Key

STXXSMQHYQHLDA-XGUXPKHRSA-N

InChi Code

InChI=1S/C46H53ClN10O5/c1-29(2)37-24-38(42(59)25-41(37)58)44-52-53-46(61)57(44)34-8-3-30(4-9-34)27-54-19-21-55(22-20-54)28-31-15-17-56(18-16-31)43-14-13-40(50-51-43)45(60)49-33-6-11-35(12-7-33)62-36-10-5-32(26-48)39(47)23-36/h3-5,8-10,13-14,23-25,29,31,33,35,58-59H,6-7,11-12,15-22,27-28H2,1-2H3,(H,49,60)(H,53,61)/t33-,35-

SMILES Code

ClC1=C(C#N)C=CC(O[C@H]2CC[C@H](NC(C3=NN=C(N4CCC(CN5CCN(CC6=CC=C(N7C(C8=C(O)C=C(O)C(C(C)C)=C8)=NNC7=O)C=C6)CC5)CC4)C=C3)=O)CC2)=C1

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 861.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer Siqi Zhang, Xiaolei Meng, Sai Zhang, Baohu Li, Wencong Jin, Chengwei Zhang, Zhaojuan Liu, Xiaolin Hu, Ling Ge, Zhonghao Yu, Zhuoyue Li, Shumin Ma, Xiao Wang, Liming Li, and Chong Qin Journal of Medicinal Chemistry Article ASAP DOI: 10.1021/acs.jmedchem.2c01970